JPM HC 2025??
Anyone have insight on how JPM HC is doing lately?? Thought it was regarded as the best group on the street but saw that Evercore just poached one of the co-heads of HC today.
Also noticed JPM has not been on majority of the major HC deals this year. Below is the list of 10bn+ HC deals announced in 2025 and looks like Centerview, GS and MS are dominating (Also no BofA???)
- JNJ / Intra-Cellular ($14.6bn) Buy-side: Citi | Sell-side: Centerview & Jefferies
- Sycamore / Walgreens ($23.7bn) Buy-side: UBS & GS & JPM & Citi & WF | Sell-side: Centerview & MS
- Merck / Verona ($10bn) Buy-side: Citi & MS | Sell-side: Centerview
- BD / Waters ($17.5bn) Buy-side: Barclays | Sell-side: Citi & Evercore
- Blackstone & TPG / Hologic ($18.3bn) Buy-side: Citi | Sell-side: GS
- Novartis / Avidity ($12bn) Buy-side: Gordon & Dyal | Sell-side: Barclays & GS
- Kimberly Clark / Kenvue ($48.7bn) Buy-side: PJT & JPM | Sell-side: Centerview & GS
- Abbott / Exact Sciences ($21bn) Buy-side: MS | Sell-side: Centerview & XMS
.
For 2025, top groups are CVP for biopharma sell-side M&A. Best large-cap buy-side banks are GS and Citi. HC services Moelis is fine.
Citi HC to the moon! JPM falloff in HC to CVP/Citi might be at the hands of that former JPM/PWP hire they made along with the GS HC senior going to Citi a few years back. CVP Tokat is the second coming of Jesus in HC.
lol
Enim quia nulla ipsum et consequatur adipisci. Ea maxime voluptatum vel voluptatum et voluptates.
Illum dolorem dolorem sit sint id et ut voluptates. Molestias quia et accusamus placeat. Qui at molestiae eius et. Omnis accusamus et voluptatem. Quae officia quas voluptas similique ipsum sapiente. Aliquam aut officiis suscipit cupiditate.
Qui doloribus magnam unde ut. Dolorem eum dicta nemo omnis quidem commodi eligendi.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...